The role of MARS in patients suffering from hypoxic liver failure secondary to cardiogenic shock

ITBM-RBM

Volumn 23, Issue SUPPL. 1, 2002, Pages 61-66

  El Banayosy, A ^a   Kizner, L ^a   Schueler, V ^a   Bergmeier, S ^a   Cobaugh, D ^a   Koerfer, R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Hypoxic liver failure; MARS in acute

Indexed keywords

ALBUMIN; BILIRUBIN; CHARCOAL;

ADULT; AGED; ALBUMIN DIALYSIS; ANION EXCHANGE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DIALYSIS; EVALUATION; FEMALE; HEART SURGERY; HEPATORENAL SYNDROME; HUMAN; LIVER FAILURE; LIVER ISCHEMIA; MALE; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TECHNOLOGY;

EID: 0036435232     PISSN: 12979562     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1297-9562(02)80047-x     Document Type: Conference Paper

References (13)

1. Mitzner SR, Stange J, Klammt S, Risler T, Erley M, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-86.
2. Mitzner SR, Klammt S, Peszynski P, Hickstein H, Korten G, Stange J, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbant recirculating system. Ther Apheresis 2001; 5: 417-22.
3. Sorkine P, Abraham RB, Szold O, Biderman P, Kidron A, Merchav H, et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29: 1332-6.
4. Awad SS, Rich PB, Kolla S, Younger JG, Reickert CA, Downing VP, et al. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO 1997; 43: M745-M749.
5. Stange J, Mitzner S, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular Adsorbent Recirculating System (MARS). Clinical results of a new membrane based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319-30.
6. Awad SS, Sawada S, Soldes OS, Rich PB, Klein R, Alarcon WH, et al. Can the clearance of tumor necrosis factor alpha and interleukin-6 be enhanced using an albumin dialysate hemodiafiltration system? ASAIO 1999; 45: 47-9.
7. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Internat J Artif Organs 1996; 19: 677-91.
8. Goldberg R, Gore J, Alpert J. Cardiogenic shock after acute myocardial Incidence infarction, and mortality from a community wide perspective, 1975-1988. N Engl J Med 1991; 325: 1117-22.
9. Hands ME, Rutherford JD, Muller JE. The in-hospital development of cardiogenic shock after myocardial infarction. Incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol 1989; 14: 40-6.
10. Leor J, Goldbourt U, Reicher-Riess H, Kaplinsky E, Behar S, SPRINT Study Group. Cardiogenic Shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors and outcome. Am J Med 1993; 94: 265-73.
11. Califf RM, Bengston JR. Cardiogenic shock. N Engl J Med 1994; 330: 1724-30.
12. Rahmann TM, Hodgson HJF. Review article: Liver support systems in acute hepatic failure. Aliment Pharmacol Ther 1999; 13: 1255-72.
13. Hughes RD, Courtney JM. Dialysis/adsorption techniques for acute liver failure. In: Lee W, Williams R, Eds. Acute Liver Failure, Cambridge, New York, Melbourne, Cambridge University Press; 1997. pp. 278-84.